Andrew James King is CSO at CHINOOK THERAPEUTICS, INC. (KDNY). They have made 10 open-market trades across 1 company since 2021, most recently 2026-02-12.
CIK 0001823187
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 10 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| KDNY | SELL | 2023-08-01 | 2023-08-01 | $39.03 | $46K | +0.2% | N/A | N/A |
| KDNY | SELL · 10b5-1 | 2023-04-03 | 2023-04-05 | $23.34 | $117K | -1.3% | -8.9% | +74.0% |
| KDNY | SELL | 2023-02-10 | 2023-02-15 | $23.75 | $57K | -0.5% | +1.3% | +1.9% |
| KDNY | SELL | 2023-01-31 | 2023-02-02 | $24.68 | $160K | -5.1% | -6.7% | -23.0% |
| KDNY | SELL | 2023-01-03 | 2023-01-04 | $25.82 | $258K | +4.2% | -4.4% | -11.2% |
| KDNY | SELL | 2022-10-06 | 2022-10-11 | $19.69 | $140K | +8.1% | +18.3% | +30.9% |
| KDNY | SELL | 2022-08-04 | 2022-08-05 | $20.00 | $100K | +6.9% | +0.6% | +7.1% |
| KDNY | SELL | 2022-07-11 | 2022-07-13 | $18.09 | $90K | -1.7% | +11.2% | +2.9% |
| KDNY | SELL | 2022-04-11 | 2022-04-13 | $15.36 | $77K | -7.7% | -11.4% | +13.6% |
| KDNY | SELL · 10b5-1 | 2022-02-18 | 2022-02-23 | $13.00 | $33K | -3.7% | +25.3% | +20.1% |
| KDNY | SELL | 2022-02-11 | 2022-02-14 | $12.74 | $32K | +0.6% | +6.6% | +6.6% |
| KDNY | SELL · 10b5-1 | 2022-02-10 | 2022-02-11 | $13.31 | $33K | +3.9% | -2.9% | +2.5% |
| KDNY | SELL | 2021-11-09 | 2021-11-12 | $13.53 | $68K | +0.2% | -5.3% | -20.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.